Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-02-14
12:57 pm
Purchase		13GTRACON Pharmaceuticals, Inc.
TCON		Ikarian Capital LLC2,765,530
12.5%		74,420increase
(+2.77%)		View
2023-02-14
11:26 am
Sale		13GX4 Pharmaceuticals, Inc.
XFOR		Ikarian Capital LLC349,133
0.3%		-1,915,358decrease
(-84.58%)		View
2023-02-14
11:03 am
Sale		13GMilestone Pharmaceuticals Inc.
MIST		Ikarian Capital LLC460,416
1.3%		-1,289,627decrease
(-73.69%)		View
2023-02-14
11:02 am
Sale		13GBellicum Pharmaceuticals, Inc.
BLCM		Ikarian Capital LLC448,101
5.2%		-48,655decrease
(-9.79%)		View
2022-02-14
4:43 pm
Sale		13GX4 Pharmaceuticals, Inc.
XFOR		Ikarian Capital LLC2,264,491
8.1%		-360,497decrease
(-13.73%)		View
2022-02-14
4:41 pm
Sale		13GaTyr Pharma, Inc.
LIFE		Ikarian Capital LLC35,048
0.1%		-853,532decrease
(-96.06%)		View
2022-02-14
4:39 pm
Sale		13GProtara Therapeutics, Inc.
TARA		Ikarian Capital LLC279,256
2.5%		-370,286decrease
(-57.01%)		View
2022-02-14
4:37 pm
Sale		13GTRACON Pharmaceuticals, Inc.
TCON		Ikarian Capital LLC2,691,110
13.8%		-25,730decrease
(-0.95%)		View
2022-02-14
4:36 pm
Sale		13GMilestone Pharmaceuticals Inc.
MIST		Ikarian Capital LLC1,750,043
5.9%		-86,502decrease
(-4.71%)		View
2022-02-14
4:36 pm
Sale		13GOdonate, Inc.
ODTC		Ikarian Capital LLC1,340,631
3.5%		-645,781decrease
(-32.51%)		View
2022-02-14
4:35 pm
Sale		13GscPharmaceuticals Inc.
SCPH		Ikarian Capital LLC901,362
3.3%		-564,785decrease
(-38.52%)		View
2022-02-14
4:34 pm
Sale		13GScience 37 Holdings, Inc.
SNCE		Ikarian Capital LLC0
0%		-512,450decrease
(Position Closed)		View
2022-02-14
4:34 pm
Sale		13GCyclacel Pharmaceuticals, Inc.
CYCC		Ikarian Capital LLC99,422
1%		-300,578decrease
(-75.14%)		View
2022-02-14
4:32 pm
Sale		13GBellicum Pharmaceuticals, Inc.
BLCM		Ikarian Capital LLC496,756
5.9%		-3,244decrease
(-0.65%)		View
2022-02-14
4:32 pm
Sale		13GKalVista Pharmaceuticals, Inc.
KALV		Ikarian Capital LLC36,576
0.2%		-1,027,385decrease
(-96.56%)		View
2022-02-14
4:31 pm
Sale		13GTempest Therapeutics Inc.
MLND		Ikarian Capital LLC58,803
0.9%		-1,289,218decrease
(-95.64%)		View
2022-02-14
4:30 pm
Sale		13GLyra Therapeutics, Inc.
LYRA		Ikarian Capital LLC394,536
3%		-420,828decrease
(-51.61%)		View
2021-09-17
3:00 pm
Purchase		13GaTyr Pharma, Inc.
LIFE		Ikarian Capital LLC888,580
5.3%		888,580increase
(New Position)		View
2021-07-02
4:05 pm
Purchase		13GOdonate, Inc.
ODTC		Ikarian Capital LLC1,986,412
5.2%		1,986,412increase
(New Position)		View
2021-04-08
09:02 am
Purchase		13GX4 Pharmaceuticals, Inc.
XFOR		Ikarian Capital LLC2,624,988
11.1%		1,798,564increase
(+217.63%)		View
Goto 0, 1, 2, Next